Table 2.
Clinical outcomes and management of patients hospitalized with COVID-19 (n = 1092).
| Total n = 1092 n (%) |
SCZ patients n = 15 n (%) |
Non-SCZ patients n = 1077 n (%) |
P-value | |
|---|---|---|---|---|
| Outcomes and management | ||||
| In-hospital mortality | 98 (9.0) | 4 (26.7) | 94 (8.7) | 0.038 |
| ICU admission | 191 (17.5) | 2 (13.3) | 189 (17.6) | 0.999 |
| Recourse to mechanical ventilation | 106 (9.7) | 1 (6.7) | 105 (9.8) | 0.999 |
| Recourse to continuous renal-replacement therapy | 21 (1.9) | 0 (0.0) | 21 (2.0) | 0.999 |
| Palliative care | 49 (4.5) | 1 (6.7) | 48 (4.5) | 0.500 |
| Characteristics of stay | ||||
| Length of ICU stay, median (IQR) — No. of days | 12.0 (4.0–28.0) | –a | 13.0 (4.0–28.0) | – |
| Length of hospital stay, median (IQR) — No. of days | 7.0 (4.0–14.0) | 10 (7.0–15.0) | 7.0 (4.0–14.0) | 0.196 |
Data based on the 10th revision of the International Statistical Classification of Diseases and common classification of medical acts from the Programme de Médicalisation des Systèmes d’Information (PMSI) – French medico-administrative database based on diagnosis related-groups (DRG).
ICU: intensive care unit.
P-value in bold: statistical significance.
a
Two SCZ patients were admitted to ICU with a length of ICU stay of 3 days and 5 days, respectively.